Literature DB >> 15175150

Propagating prions in fungi and mammals.

Mick F Tuite1, Nadejda Koloteva-Levin.   

Abstract

Prions constitute a rare class of protein, which can switch to a robust amyloid form and then propagate that form in the absence of a nucleic acid determinant, thereby creating a unique, protein-only infectious agent. Details of the mechanism that drives conversion to the prion form and then subsequent propagation of that form are beginning to emerge using a range of in vivo and in vitro approaches. Recent studies on both mammalian and fungal prions are providing a greater understanding of the structural features that distinguish prions from non-transmissible amyloids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175150     DOI: 10.1016/j.molcel.2004.05.012

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  12 in total

1.  Modulation of prion formation, aggregation, and toxicity by the actin cytoskeleton in yeast.

Authors:  Elena E Ganusova; Laura N Ozolins; Srishti Bhagat; Gary P Newnam; Renee D Wegrzyn; Michael Y Sherman; Yury O Chernoff
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

Review 2.  Prions of fungi: inherited structures and biological roles.

Authors:  Reed B Wickner; Herman K Edskes; Frank Shewmaker; Toru Nakayashiki
Journal:  Nat Rev Microbiol       Date:  2007-08       Impact factor: 60.633

3.  The [URE3] prion is not conserved among Saccharomyces species.

Authors:  Nicolas Talarek; Laurent Maillet; Christophe Cullin; Michel Aigle
Journal:  Genetics       Date:  2005-06-14       Impact factor: 4.562

4.  Influence of prion variant and yeast strain variation on prion-molecular chaperone requirements.

Authors:  Justin K Hines; Takashi Higurashi; Mathangi Srinivasan; Elizabeth A Craig
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

5.  Differences in prion strain conformations result from non-native interactions in a nucleus.

Authors:  Yumiko Ohhashi; Kazuki Ito; Brandon H Toyama; Jonathan S Weissman; Motomasa Tanaka
Journal:  Nat Chem Biol       Date:  2010-01-17       Impact factor: 15.040

6.  Role of Hsp104 in the propagation and inheritance of the [Het-s] prion.

Authors:  Laurent Malato; Suzana Dos Reis; Laura Benkemoun; Raimon Sabaté; Sven J Saupe
Journal:  Mol Biol Cell       Date:  2007-09-19       Impact factor: 4.138

Review 7.  The Mad2 partial unfolding model: regulating mitosis through Mad2 conformational switching.

Authors:  John J Skinner; Stacey Wood; James Shorter; S Walter Englander; Ben E Black
Journal:  J Cell Biol       Date:  2008-11-24       Impact factor: 10.539

Review 8.  "Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?

Authors:  L K Medina-Kauwe
Journal:  Adv Drug Deliv Rev       Date:  2007-07-05       Impact factor: 15.470

9.  Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs.

Authors:  Déborah Tribouillard-Tanvier; Suzana Dos Reis; Fabienne Gug; Cécile Voisset; Vincent Béringue; Raimon Sabate; Ema Kikovska; Nicolas Talarek; Stéphane Bach; Chenhui Huang; Nathalie Desban; Sven J Saupe; Surachai Supattapone; Jean-Yves Thuret; Stéphane Chédin; Didier Vilette; Hervé Galons; Suparna Sanyal; Marc Blondel
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

10.  Prion-specific Hsp40 function: The role of the auxilin homolog Swa2.

Authors:  Emily E Oliver; Elizabeth M Troisi; Justin K Hines
Journal:  Prion       Date:  2017-05-04       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.